These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 38799035)

  • 1. Evaluating anthelmintic activity through
    Hernando G; Bouzat C
    MethodsX; 2024 Jun; 12():102743. PubMed ID: 38799035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anthelmintic activity of KSI-4088 against Caenorhabditis elegans.
    Kaewintajuk K; Cho PY; Kim SY; Lee ES; Lee HK; Choi EB; Park H
    Parasitol Res; 2010 Jun; 107(1):27-30. PubMed ID: 20309581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anthelmintic drug actions in resistant and susceptible C. elegans revealed by electrophysiological recordings in a multichannel microfluidic device.
    Weeks JC; Robinson KJ; Lockery SR; Roberts WM
    Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):607-628. PubMed ID: 30503202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of anthelmintic activity of the acetone extract and constituents of Typha capensis against animal parasitic Haemonchus contortus and free-living Caenorhabditis elegans.
    Ondua M; Mfotie Njoya E; Abdalla MA; McGaw LJ
    Parasitol Res; 2021 Oct; 120(10):3437-3449. PubMed ID: 34424423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caenorhabditis elegans muscle Cys-loop receptors as novel targets of terpenoids with potential anthelmintic activity.
    Hernando G; Turani O; Bouzat C
    PLoS Negl Trop Dis; 2019 Nov; 13(11):e0007895. PubMed ID: 31765374
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using C. elegans Forward and Reverse Genetics to Identify New Compounds with Anthelmintic Activity.
    Mathew MD; Mathew ND; Miller A; Simpson M; Au V; Garland S; Gestin M; Edgley ML; Flibotte S; Balgi A; Chiang J; Giaever G; Dean P; Tung A; Roberge M; Roskelley C; Forge T; Nislow C; Moerman D
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005058. PubMed ID: 27755544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high-throughput screen for the identification of compounds that inhibit nematode gene expression by targeting spliced leader trans-splicing.
    Pandarakalam GC; Speake M; McElroy S; Alturkistani A; Philippe L; Pettitt J; Müller B; Connolly B
    Int J Parasitol Drugs Drug Resist; 2019 Aug; 10():28-37. PubMed ID: 31015150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the novel anthelmintic emodepside on the locomotion, egg-laying behaviour and development of Caenorhabditis elegans.
    Bull K; Cook A; Hopper NA; Harder A; Holden-Dye L; Walker RJ
    Int J Parasitol; 2007 May; 37(6):627-36. PubMed ID: 17157854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caenorhabditis elegans in anthelmintic research - Old model, new perspectives.
    Hahnel SR; Dilks CM; Heisler I; Andersen EC; Kulke D
    Int J Parasitol Drugs Drug Resist; 2020 Dec; 14():237-248. PubMed ID: 33249235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anthelmintic drugs and nematicides: studies in Caenorhabditis elegans.
    Holden-Dye L; Walker RJ
    WormBook; 2014 Dec; ():1-29. PubMed ID: 25517625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery.
    Herath HMPD; Taki AC; Rostami A; Jabbar A; Keiser J; Geary TG; Gasser RB
    Biotechnol Adv; 2022; 57():107937. PubMed ID: 35271946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthelmintic effects of forage chicory (Cichorium intybus) against free-living and parasitic stages of Cooperia oncophora.
    Peña-Espinoza M; Williams AR; Thamsborg SM; Simonsen HT; Enemark HL
    Vet Parasitol; 2017 Aug; 243():204-207. PubMed ID: 28807295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phenotypic screen of the Global Health Priority Box identifies an insecticide with anthelmintic activity.
    Shanley HT; Taki AC; Byrne JJ; Nguyen N; Wells TNC; Jabbar A; Sleebs BE; Gasser RB
    Parasit Vectors; 2024 Mar; 17(1):131. PubMed ID: 38486232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model nematodes as a practical innovation to promote high throughput screening of natural products for anthelmintics discovery in South Asia: Current challenges, proposed practical and conceptual solutions.
    Kamal M; Mukherjee S; Joshi B; Sindhu ZU; Wangchuk P; Haider S; Ahmed N; Talukder MH; Geary TG; Yadav AK
    Mol Biochem Parasitol; 2023 Dec; 256():111594. PubMed ID: 37730126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caenorhabditis elegans is a useful model for anthelmintic discovery.
    Burns AR; Luciani GM; Musso G; Bagg R; Yeo M; Zhang Y; Rajendran L; Glavin J; Hunter R; Redman E; Stasiuk S; Schertzberg M; Angus McQuibban G; Caffrey CR; Cutler SR; Tyers M; Giaever G; Nislow C; Fraser AG; MacRae CA; Gilleard J; Roy PJ
    Nat Commun; 2015 Jun; 6():7485. PubMed ID: 26108372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthelmintic-like activity of polyphenolic compounds and their interactions against the cattle nematode Cooperia punctata.
    Escareño-Díaz S; Alonso-Díaz MA; Mendoza de Gives P; Castillo-Gallegos E; von Son-de Fernex E
    Vet Parasitol; 2019 Oct; 274():108909. PubMed ID: 31586699
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytochemical analysis and in vitro anthelmintic activity of Lophira lanceolata (Ochnaceae) on the bovine parasite Onchocerca ochengi and on drug resistant strains of the free-living nematode Caenorhabditis elegans.
    Kalmobé J; Ndjonka D; Boursou D; Vildina JD; Liebau E
    BMC Complement Altern Med; 2017 Aug; 17(1):404. PubMed ID: 28806951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the molecular determinants of cholinergic anthelmintic sensitivity in nematodes: When novel functional validation approaches highlight major differences between the model Caenorhabditis elegans and parasitic species.
    Blanchard A; Guégnard F; Charvet CL; Crisford A; Courtot E; Sauvé C; Harmache A; Duguet T; O'Connor V; Castagnone-Sereno P; Reaves B; Wolstenholme AJ; Beech RN; Holden-Dye L; Neveu C
    PLoS Pathog; 2018 May; 14(5):e1006996. PubMed ID: 29719008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discovery technologies: Caenorhabditis elegans as a model for anthelmintic therapeutics.
    Sepúlveda-Crespo D; Reguera RM; Rojo-Vázquez F; Balaña-Fouce R; Martínez-Valladares M
    Med Res Rev; 2020 Sep; 40(5):1715-1753. PubMed ID: 32166776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in anthelmintic responses are driven by genetic differences among diverse C. elegans wild strains.
    Shaver AO; Wit J; Dilks CM; Crombie TA; Li H; Aroian RV; Andersen EC
    PLoS Pathog; 2023 Apr; 19(4):e1011285. PubMed ID: 37011090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.